{{Rsnum
|rsid=2602141
|Gene=TP53BP1
|Chromosome=15
|position=43432448
|Orientation=plus
|GMAF=0.4881
|Gene_s=TP53BP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 6.2 | 46.4 | 47.3
| HCB | 23.4 | 48.9 | 27.7
| JPT | 12.4 | 46.9 | 40.7
| YRI | 97.3 | 2.7 | 0.0
| ASW | 75.4 | 22.8 | 1.8
| CHB | 23.4 | 48.9 | 27.7
| CHD | 16.5 | 41.3 | 42.2
| GIH | 18.8 | 55.4 | 25.7
| LWK | 88.2 | 11.8 | 0.0
| MEX | 17.2 | 41.4 | 41.4
| MKK | 62.2 | 33.3 | 4.5
| TSI | 8.8 | 52.0 | 39.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=24316395
|Title=Common Genetic Variants in 53BP1 Associated with Non-small Cell Lung Cancer Risk in Han Chinese
}}

{{PMID Auto
|PMID=15987456
|Title=TP53-binding protein variants and breast cancer risk: a case-control study.
|OA=1
}}

{{PMID Auto
|PMID=16741161
|Title=Variants in the GH-IGF axis confer susceptibility to lung cancer.
|OA=1
}}

{{PMID Auto
|PMID=21303977
|Title=Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=24761925
|Title=Association between the TP53BP1 rs2602141 A/C Polymorphism and Cancer Risk: A Systematic Review and Meta-Analysis
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}